Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jimmy Gollihar is active.

Publication


Featured researches published by Jimmy Gollihar.


Science | 2016

Synthetic evolutionary origin of a proofreading reverse transcriptase.

Jared W. Ellefson; Jimmy Gollihar; Raghav Shroff; Haridha Shivram; Vishwanath R. Iyer; Andrew D. Ellington

Making error-free DNA from RNA DNA polymerase enzymes copy DNA into new strands of identical DNA. Reverse transcriptase (RT) enzymes copy RNA into DNA. Unlike many DNA polymerases, RT enzymes do not have a proofreading function that checks for errors in the newly synthesized DNA. Ellefson et al. use in vitro directed evolution and protein engineering to build an error-correcting RT from a prokaryotic DNA polymerase. The RT “xenopolymerase” shows increased fidelity as compared to natural RTs and should streamline and increase the precision of transcriptomics methods. Science, this issue p. 1590 In vitro evolution and protein engineering have converted a DNA polymerase into an error-checking reverse transcriptase enzyme. Most reverse transcriptase (RT) enzymes belong to a single protein family of ancient evolutionary origin. These polymerases are inherently error prone, owing to their lack of a proofreading (3′- 5′ exonuclease) domain. To determine if the lack of proofreading is a historical coincidence or a functional limitation of reverse transcription, we attempted to evolve a high-fidelity, thermostable DNA polymerase to use RNA templates efficiently. The evolutionarily distinct reverse transcription xenopolymerase (RTX) actively proofreads on DNA and RNA templates, which greatly improves RT fidelity. In addition, RTX enables applications such as single-enzyme reverse transcription–polymerase chain reaction and direct RNA sequencing without complementary DNA isolation. The creation of RTX confirms that proofreading is compatible with reverse transcription.


Angewandte Chemie | 2017

Coupling Sensitive Nucleic Acid Amplification with Commercial Pregnancy Test Strips.

Yan Du; Arti Pothukuchy; Jimmy Gollihar; Armin Nourani; Bingling Li; Andrew D. Ellington

The detection of nucleic acid biomarkers for point-of-care (POC) diagnostics is currently limited by technical complexity, cost, and time constraints. To overcome these shortcomings, we have combined loop-mediated isothermal amplification (LAMP), programmable toehold-mediated strand-exchange signal transduction, and standard pregnancy test strips. The incorporation of an engineered hCG-SNAP fusion reporter protein (human chorionic gonadotropin-O6 -alkylguanine-DNA alkyltransferase) led to LAMP-to-hCG signal transduction on low-cost, commercially available pregnancy test strips. Our assay reliably detected as few as 20 copies of Ebola virus templates in both human serum and saliva and could be adapted to distinguish a common melanoma-associated SNP allele (BRAF V600E) from the wild-type sequence. The methods described are completely generalizable to many nucleic acid biomarkers, and could be adapted to provide POC diagnostics for a range of pathogens.


eLife | 2015

Fine-tuning citrate synthase flux potentiates and refines metabolic innovation in the Lenski evolution experiment

Erik M. Quandt; Jimmy Gollihar; Zachary D. Blount; Andrew D. Ellington; George Georgiou; Jeffrey E. Barrick

Evolutionary innovations that enable organisms to colonize new ecological niches are rare compared to gradual evolutionary changes in existing traits. We discovered that key mutations in the gltA gene, which encodes citrate synthase (CS), occurred both before and after Escherichia coli gained the ability to grow aerobically on citrate (Cit+ phenotype) during the Lenski long-term evolution experiment. The first gltA mutation, which increases CS activity by disrupting NADH-inhibition of this enzyme, is beneficial for growth on the acetate and contributed to preserving the rudimentary Cit+ trait from extinction when it first evolved. However, after Cit+ was refined by further mutations, this potentiating gltA mutation became deleterious to fitness. A second wave of beneficial gltA mutations then evolved that reduced CS activity to below the ancestral level. Thus, dynamic reorganization of central metabolism made colonizing this new nutrient niche contingent on both co-opting and overcoming a history of prior adaptation. DOI: http://dx.doi.org/10.7554/eLife.09696.001


Microbiology | 2014

Indole inhibition of N-acylated homoserine lactone-mediated quorum signalling is widespread in Gram-negative bacteria.

Benjamin Hidalgo-Romano; Jimmy Gollihar; Stacie A. Brown; Marvin Whiteley; Ernesto Valenzuela; Heidi B. Kaplan; Thomas K. Wood; Robert J. C. McLean

The LuxI/R quorum-sensing system and its associated N-acylated homoserine lactone (AHL) signal is widespread among Gram-negative bacteria. Although inhibition by indole of AHL quorum signalling in Pseudomonas aeruginosa and Acinetobacter oleivorans has been reported previously, it has not been documented among other species. Here, we show that co-culture with wild-type Escherichia coli, but not with E. coli tnaA mutants that lack tryptophanase and as a result do not produce indole, inhibits AHL-regulated pigmentation in Chromobacterium violaceum (violacein), Pseudomonas chlororaphis (phenazine) and Serratia marcescens (prodigiosin). Loss of pigmentation also occurred during pure culture growth of Chro. violaceum, P. chlororaphis and S. marcescens in the presence of physiologically relevant indole concentrations (0.5-1.0 mM). Inhibition of violacein production by indole was counteracted by the addition of the Chro. violaceum cognate autoinducer, N-decanoyl homoserine lactone (C10-HSL), in a dose-dependent manner. The addition of exogenous indole or co-culture with E. coli also affected Chro. violaceum transcription of vioA (violacein pigment production) and chiA (chitinase production), but had no effect on pykF (pyruvate kinase), which is not quorum regulated. Chro. violaceum AHL-regulated elastase and chitinase activity were inhibited by indole, as was motility. Growth of Chro. violaceum was not affected by indole or C10-HSL supplementation. Using a nematode-feeding virulence assay, we observed that survival of Caenorhabditis elegans exposed to Chro. violaceum, P. chlororaphis and S. marcescens was enhanced during indole supplementation. Overall, these studies suggest that indole represents a general inhibitor of AHL-based quorum signalling in Gram-negative bacteria.


Nature Chemical Biology | 2016

Addicting diverse bacteria to a noncanonical amino acid

Drew Tack; Jared W. Ellefson; Ross Thyer; Bo Wang; Jimmy Gollihar; Matthew T Forster; Andrew D. Ellington

Engineered orthogonal translation systems have greatly enabled the expansion of the genetic code using noncanonical amino acids (NCAAs). However, the impact of NCAAs on organismal evolution remains unclear, in part because it is difficult to force the adoption of new genetic codes in organisms. By reengineering TEM-1 β-lactamase to be dependent on a NCAA, we maintained bacterial NCAA dependence for hundreds of generations without escape.


Cancer Immunology, Immunotherapy | 2018

Identification of tumor-reactive B cells and systemic IgG in breast cancer based on clonal frequency in the sentinel lymph node

Jonathan R. McDaniel; Stephanie C. Pero; William N. Voss; Girja S. Shukla; Yu-Jing Sun; Sebastian Schaetzle; Chang-Han Lee; Andrew P. Horton; Seth P. Harlow; Jimmy Gollihar; Jared W. Ellefson; Christopher C. Krag; Yuri Tanno; Nikoletta Sidiropoulos; George Georgiou; Gregory C. Ippolito; David N. Krag

A better understanding of antitumor immune responses is the key to advancing the field of cancer immunotherapy. Endogenous immunity in cancer patients, such as circulating anticancer antibodies or tumor-reactive B cells, has been historically yet incompletely described. Here, we demonstrate that tumor-draining (sentinel) lymph node (SN) is a rich source for tumor-reactive B cells that give rise to systemic IgG anticancer antibodies circulating in the bloodstream of breast cancer patients. Using a synergistic combination of high-throughput B-cell sequencing and quantitative immunoproteomics, we describe the prospective identification of tumor-reactive SN B cells (based on clonal frequency) and also demonstrate an unequivocal link between affinity-matured expanded B-cell clones in the SN and antitumor IgG in the blood. This technology could facilitate the discovery of antitumor antibody therapeutics and conceivably identify novel tumor antigens. Lastly, these findings highlight the unique and specialized niche the SN can fill in the advancement of cancer immunotherapy.


Molecular Biology and Evolution | 2016

Expanded genetic codes create new mutational routes to rifampicin resistance in Escherichia coli

Michael J. Hammerling; Jimmy Gollihar; Catherine Mortensen; Razan N. Alnahhas; Andrew D. Ellington; Jeffrey E. Barrick

Until recently, evolutionary questions surrounding the nature of the genetic code have been mostly limited to the realm of conjecture, modeling, and simulation due to the difficulty of altering this fundamental property of living organisms. Concerted genome and protein engineering efforts now make it possible to experimentally study the impact of alternative genetic codes on the evolution of biological systems. We explored how Escherichia coli strains that incorporate a 21st nonstandard amino acid (nsAA) at the recoded amber (TAG) stop codon evolve resistance to the antibiotic rifampicin. Resistance to rifampicin arises from chromosomal mutations in the β subunit of RNA polymerase (RpoB). We found that a variety of mutations that lead to substitutions of nsAAs in the essential RpoB protein confer robust rifampicin resistance. We interpret these results in a framework in which an expanded code can increase evolvability in two distinct ways: by adding a new letter with unique chemical properties to the protein alphabet and by altering the mutational connectivity of amber-adjacent codons by converting a lethal nonsense mutation into a missense mutation. Finally, we consider the implications of these results for the evolution of alternative genetic codes. In our experiments, reliance on a mutation to a reassigned codon for a vital trait is not required for the long-term maintenance of an expanded genetic code and may even destabilize incorporation of an nsAA, a result that is consistent with the codon capture model of genetic code evolution.


Molecular Pharmaceutics | 2017

Charge shielding prevents aggregation of supercharged GFP variants at high protein concentration

Joshua R. Laber; Barton J. Dear; Matheus L. Martins; Devin E. Jackson; Andrea M. DiVenere; Jimmy Gollihar; Andrew D. Ellington; Thomas M. Truskett; Keith P. Johnston; Jennifer A. Maynard

Understanding protein stability is central to combatting protein aggregation diseases and developing new protein therapeutics. At the high concentrations often present in biological systems, purified proteins can exhibit undesirable high solution viscosities and poor solubilities mediated by short-range electrostatic and hydrophobic protein-protein interactions. The interplay between protein amino acid sequence, protein structure, and solvent conditions to minimize protein-protein interactions is key to designing well-behaved pharmaceutical proteins. However, theoretical approaches have yet to yield a general framework to address these problems. Here, we analyzed the high concentration behavior of superfolder GFP (sfGFP) and two supercharged sfGFP variants engineered to have formal charges of -18 or +15. Under low cosolute conditions, sfGFP and the -18 variant formed a gel or phase separated at ∼10 mg/mL. Under conditions that screen surface charges, including formulations with high histidine or high NaCl concentrations, all three variants attained concentrations up to 250 mg/mL with moderate viscosities. Moreover, all three variants exhibited very similar viscosity-concentration profiles over this range. This effect was not mimicked by high sugar concentrations that exert excluded-volume effects without shielding charge. Collectively, these data demonstrate that charge shielding neutralizes not only long-range electrostatic interactions but also, surprisingly, short-range electrostatic effects due to surface charge anisotropy. This work shows that supercharged sfGFP behavior under high ionic strength is largely determined by particle geometry, a conclusion that is supported by colloid models and may be applicable to pharmaceutically relevant proteins.


Science | 2014

Many Paths to the Origin of Life

Jimmy Gollihar; Matthew Levy; Andrew D. Ellington


Nature Protocols | 2017

Compartmentalized partnered replication for the directed evolution of genetic parts and circuits

Zhanar Abil; Jared W. Ellefson; Jimmy Gollihar; Ella Watkins; Andrew D. Ellington

Collaboration


Dive into the Jimmy Gollihar's collaboration.

Top Co-Authors

Avatar

Andrew D. Ellington

University of Texas at Austin

View shared research outputs
Top Co-Authors

Avatar

Jared W. Ellefson

University of Texas at Austin

View shared research outputs
Top Co-Authors

Avatar

Arti Pothukuchy

University of Texas at Austin

View shared research outputs
Top Co-Authors

Avatar

George Georgiou

University of Texas at Austin

View shared research outputs
Top Co-Authors

Avatar

Jeffrey E. Barrick

University of Texas at Austin

View shared research outputs
Top Co-Authors

Avatar

Raghav Shroff

University of Texas at Austin

View shared research outputs
Top Co-Authors

Avatar

Aashiq H. Kachroo

University of Texas at Austin

View shared research outputs
Top Co-Authors

Avatar

Andrea M. DiVenere

University of Texas at Austin

View shared research outputs
Top Co-Authors

Avatar

Andrew P. Horton

University of Texas at Austin

View shared research outputs
Top Co-Authors

Avatar

Armin Nourani

University of Texas at Austin

View shared research outputs
Researchain Logo
Decentralizing Knowledge